Summary The European Association for Neuro-Oncology guideline provides
recommendations for the clinical care of adult patients with astrocytic and oligodendroglial …

In response to major changes in diagnostic algorithms and the publication of mature results
from various large clinical trials, the European Association of Neuro-Oncology (EANO) …

This guideline provides recommendations for diagnostic and therapeutic procedures for
patients with malignant gliomas. We differentiate evidence-based standards from …

Importance Previous histologic classifications of brain tumors have been limited by
discrepancies in diagnoses reported by neuropathologists and variability in outcomes and …

Purpose To provide guidance to clinicians regarding therapy for diffuse astrocytic and
oligodendroglial tumors in adults. Methods ASCO and the Society for Neuro-Oncology …

Background As many glioblastoma patients are in a poor condition they are unable to
undergo the full treatment documented in clinical trials. We aimed to examine the survival …

Background: Diffuse infiltrative low‐grade gliomas of the cerebral hemispheres in the adult
are a group of tumors with distinct clinical, histological and molecular characteristics, and …

Abstract The Chinese Glioma Cooperative Group (CGCG) Guideline Panel for adult diffuse
gliomas provided recommendations for diagnostic and therapeutic procedures. The Panel …

Evidence-based practical guidelines on diagnosis, prognosis, and treatment on the most
frequent adult brain tumours are delineated. In Europe, 27,000 new cases of malignant glial …

Glioblastoma (GB) is the most common brain malignancy and accounts for over 50% of all
high-grade gliomas. Radiotherapy (RT) with concomitant and adjuvant temozolomide (TMZ) …